2008 Khaled Mohamed Altaher et al.-2008-2016 Post-COVID-19 lung Fibrosis: Imaging Characteristics and Differentiation
Keywords:
Post-COVID-19 lung fibrosis; FILD; HRCT; subpleural sparingAbstract
Background: Background: Lung fibrosis is a progressive and irreversible disease that impairs lungs’ function. The globalimpact of COVID-19 lung infection has brought attention to fibrotic lung disease. Post-COVID-19 lung fibrosis is animportant long-term complication that tend to occur in patients with prolonged ICU stays, mechanical ventilation, orcomorbidities. Differentiation of post-COVID-19 lung fibrosis from other fibrosing interstitial lung diseases (FILDs) suchas idiopathic pulmonary fibrosis (IPF),andhypersensitivity pneumonitis (HP) is essential for determine patients’ prognosisand guide their treatment. High-resolutioncomputed tomography (HRCT) plays a significant role in this differentiation byidentifying the different imaging patterns.This review article highlights the role of HRCT imaging in identifying anddifferentiating post-COVID-19 lung fibrosis from FILDs.
References
Mandal S, Balas VE, Shaw RN, Ghosh A. Prediction analysis of idiopathic pulmonary fibrosis progression from OSIC dataset. In: 2020 IEEE International Conference on Computing, Power and Communication Technologies (GUCON). IEEE; 2020:861-865.
King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083-2092.
